An Analysis of the Quality of Life and Sexual Quality of Life of Cervical Cancer Radiotherapy Patients
1 other identifier
observational
200
0 countries
N/A
Brief Summary
Cervical cancer radiotherapy patients have a decline in quality of life and sexual quality of life
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2019
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 25, 2018
CompletedFirst Posted
Study publicly available on registry
March 21, 2019
CompletedStudy Start
First participant enrolled
June 25, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2019
CompletedJune 25, 2019
June 1, 2019
1 month
November 25, 2018
June 22, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
using fact-cx4.0 to evaluate the qol of cervical cancer patients undergoing radiotherapy
Functional Assessment of Cancer Therapy-Cervix V4.0 (FACT-Cx V4.0) was used to evaluate patients'quality of life. The scale is composed of general cancer quality of life assessment scale (FACT-G) and cervical cancer specific module (CCS). It contains 5 dimensions and 42 subjects. The higher the score of positive questions, the better the quality of life. The higher the score of reverse questions, the worse the quality of life. If it is a reverse question, the original score of this question is subtracted by 4. The higher the total score, the better the quality of life. The study was conducted by face-to-face investigation of specialist nurses. All patients'investigation data were kept strictly confidential. And follow the principles of medical ethics.using spss to analysis the data.
through study completion, an average of half a year
Secondary Outcomes (1)
using fsfi to evaluate the qol of cervical cancer patients undergoing radiotherapy
through study completion, an average of half a year
Eligibility Criteria
Cervical cancer patients treated by radiotherapy
You may qualify if:
- adult female
- diagnosed with cervical cancer' and acquire therapy as part of treatment
- undertaken or have finished radiotherapy in Peking Union Medical College Hospital
- agreed with informed consent
You may not qualify if:
- with cognitive dysfunction or cannot fulfilled the questionaire
- refuse or quit the research
- submit questionnaire with missing information
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- department of radiation oncology
Study Record Dates
First Submitted
November 25, 2018
First Posted
March 21, 2019
Study Start
June 25, 2019
Primary Completion
August 1, 2019
Study Completion
September 1, 2019
Last Updated
June 25, 2019
Record last verified: 2019-06